Engineers Gate Manager’s BioCardia BCDA Stock Holding History

Engineers Gate Manager’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,457	Closed	-$95K	–	1614
2021 Q1	$95K	Buy	+1,457	New	+$91K	﹤0.01%	1710

Other funds holding BCDA

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Engineers Gate Manager's BCDA Position: Q2 2021 in Review

Engineers Gate Manager sold out of BioCardia (BCDA) in Q2 2021, closing a stake of 1,457 shares — an estimated $95K sold.

Engineers Gate Manager first reported a position in BCDA in Q1 2021 and held it in 1 quarter. The position peaked at $95K in Q1 2021. 20 funds tracked by Wall St. Rank hold BCDA as of Q2 2021.

Engineers Gate Manager reported no remaining BioCardia position as of Q2 2021 after selling out during the quarter.
Engineers Gate Manager sold 1,457 BioCardia shares in Q2 2021, an estimated $95K.
Engineers Gate Manager first reported a position in BioCardia in Q1 2021 and held it in 1 quarter.
Engineers Gate Manager's BioCardia position peaked at $95K in Q1 2021.
20 funds tracked by Wall St. Rank held BioCardia as of Q2 2021.

Based on Engineers Gate Manager's 13F filing for Q2 2021, filed 16 Aug 2021.